{"id":13977,"date":"2019-09-09T11:25:53","date_gmt":"2019-09-09T15:25:53","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13977"},"modified":"2019-09-09T11:25:53","modified_gmt":"2019-09-09T15:25:53","slug":"states-pass-record-number-of-laws-to-reel-in-drug-prices","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13977","title":{"rendered":"States Pass Record Number Of Laws To Reel In Drug Prices"},"content":{"rendered":"

(By Steven Findlay for Kaiser Health News)<\/p>\n

Whether Congress will act this year to address the affordability of prescription drugs \u2014 a\u00a0high priority among voters\u00a0\u2014 remains uncertain. But states aren\u2019t waiting.<\/p>\n

So far this year, 33 states have\u00a0enacted a record 51 laws\u00a0to address drug prices, affordability and access. That tops the previous record of 45 laws enacted in 28 states set just last year, according to the National Academy for State Health Policy, a nonprofit advocacy group that develops\u00a0model legislation\u00a0and promotes such laws.<\/p>\n

Among the new measures are those that authorize importing prescription drugs, screen for excessive price increases by drug companies and establish oversight boards to set the prices states will pay for drugs.\u00a0 Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Steven Findlay for Kaiser Health News) Whether Congress will act this year to address the affordability of prescription drugs<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,10,15],"tags":[],"class_list":["post-13977","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13977"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13977\/revisions"}],"predecessor-version":[{"id":13978,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13977\/revisions\/13978"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}